Evans WE - Search Results

1

Molybdenum Cofactor Catabolism Unravels the Physiological Role of the Drug Metabolizing Enzyme Thiopurine S-Methyltransferase.

Pristup J, Schaeffeler E, Arjune S, Hofmann U, Angel Santamaria-Araujo J, Leuthold P, Friedrich N, Nauck M, Mayr S, Haag M, Muerdter T, Marner FJ, Relling MV, Evans WE, Schwarz G, Schwab M. Pristup J, et al. Among authors: evans we. Clin Pharmacol Ther. 2022 Oct;112(4):808-816. doi: 10.1002/cpt.2637. Epub 2022 May 31. Clin Pharmacol Ther. 2022. PMID: 35538648 Free PMC article.

2

HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy.

Dervieux T, Chu Y, Su Y, Pui CH, Evans WE, Relling MV. Dervieux T, et al. Among authors: evans we. Clin Chem. 2002 Jan;48(1):61-8. Clin Chem. 2002. PMID: 11751539

3

Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.

Panetta JC, Wall A, Pui CH, Relling MV, Evans WE. Panetta JC, et al. Among authors: evans we. Clin Cancer Res. 2002 Jul;8(7):2423-9. Clin Cancer Res. 2002. PMID: 12114448

4

De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo.

Dervieux T, Brenner TL, Hon YY, Zhou Y, Hancock ML, Sandlund JT, Rivera GK, Ribeiro RC, Boyett JM, Pui CH, Relling MV, Evans WE. Dervieux T, et al. Among authors: evans we. Blood. 2002 Aug 15;100(4):1240-7. doi: 10.1182/blood-2002-02-0495. Blood. 2002. PMID: 12149204 Free article. Clinical Trial.

5

Childhood acute lymphoblastic leukemia.

Pui CH, Relling MV, Campana D, Evans WE. Pui CH, et al. Among authors: evans we. Rev Clin Exp Hematol. 2002 Jun;6(2):161-80; discussion 200-2. doi: 10.1046/j.1468-0734.2002.00067.x. Rev Clin Exp Hematol. 2002. PMID: 12196214

6

A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.

Panetta JC, Yanishevski Y, Pui CH, Sandlund JT, Rubnitz J, Rivera GK, Ribeiro R, Evans WE, Relling MV. Panetta JC, et al. Among authors: evans we. Cancer Chemother Pharmacol. 2002 Nov;50(5):419-28. doi: 10.1007/s00280-002-0511-x. Epub 2002 Sep 24. Cancer Chemother Pharmacol. 2002. PMID: 12439601 Clinical Trial.

7

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment.

Relling MV, Boyett JM, Blanco JG, Raimondi S, Behm FG, Sandlund JT, Rivera GK, Kun LE, Evans WE, Pui CH. Relling MV, et al. Among authors: evans we. Blood. 2003 May 15;101(10):3862-7. doi: 10.1182/blood-2002-08-2405. Epub 2003 Jan 16. Blood. 2003. PMID: 12531808 Free article. Clinical Trial.

8

Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.

Pui CH, Relling MV, Evans WE. Pui CH, et al. Among authors: evans we. Best Pract Res Clin Haematol. 2002 Dec;15(4):741-56. doi: 10.1053/beha.2002.0225. Best Pract Res Clin Haematol. 2002. PMID: 12617874 Review.

9

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells.

Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, Naeve CW, Relling MV, Evans WE. Cheok MH, et al. Among authors: evans we. Nat Genet. 2003 May;34(1):85-90. doi: 10.1038/ng1151. Nat Genet. 2003. PMID: 12704389

10

Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.

Dervieux T, Hancock ML, Pui CH, Rivera GK, Sandlund JT, Ribeiro RC, Boyett J, Evans WE, Relling MV. Dervieux T, et al. Among authors: evans we. Clin Pharmacol Ther. 2003 Jun;73(6):506-16. doi: 10.1016/S0009-9236(03)00063-8. Clin Pharmacol Ther. 2003. PMID: 12811360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

630 results

Search Page